Summary
- Main use
- Correction of malnutrition through intravenous administration of nutrients (fluids, electrolytes, amino acids, etc.)
- Who receives it
- Adults
- Adult administration
- Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 2.0mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.08g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.54g, glucose 4.8g, and fat 1.6g per kg of body weight)
Ingredients
- Glucose Monohydrate132g
- Monobasic Sodium Phosphate Dihydrate1872mg
- Zinc Acetate Hydrate5.264mg
- Soybean Oil20g
- Triglycerides Medium-Chain20g
- Isoleucine2.256g
- L-Leucine3.008g
- Lysine Hydrochloride2.728g
- Methionine1.88g
- Phenylalanine3.368g
- Threonine1.744g
- Tryptophan0.544g
- Valine2.496g
- Arginine2.592g
- L-Histidine Hydrochloride Monohydrate1.624g
- Alanine4.656g
- Aspartic Acid1.44g
- Glutamic Acid3.368g
- Glycine1.584g
- Proline3.264g
- Serine2.88g
- Sodium Hydroxide0.781g
- Sodium Chloride0.402g
- Sodium Acetate Hydrate0.222g
- Potassium Acetate2.747g
- Magnesium Acetate Tetrahydrate0.686g
- Calcium Chloride Hydrate0.47g
- Importer
- B.Braun Korea Co., Ltd
Efficacy & effects
Correction of malnutrition through intravenous administration of nutrients (fluids, electrolytes, amino acids, etc.)
View approved original textHide original text
This medication provides necessary fluids, electrolytes, amino acids, and calories intravenously to maintain and restore nutritional status for patients who are unable to intake nutrition orally or through the gastrointestinal tract. It is used for nutritional supplementation therapy when eating is impossible or insufficient.
How it is given
Adult administration
Administer by central venous infusion. Determine the infusion rate based on the total dose, the characteristics of the final admixture to be infused, the daily dose, and the infusion time. In general, gradually increase the dose over the first 30 minutes of infusion until the appropriate dose is reached. There is no set limit on the duration of administration; however, appropriate minerals and vitamins should be provided during long-term administration. Do not exceed a maximum infusion rate of 2.0mL/kg/hour. (Equivalent to amino acids 0.08 g/kg/hour, glucose 0.24 g/kg/hour, and fat 0.08g/kg/hour) Determine the dose according to the patient's condition, energy expenditure, and metabolic requirements. - Determine the dose according to the patient's nutritional status and degree of catabolism, but do not exceed 40kcal/kg per day. Exceptions may be made in special cases, such as patients with burns. - Maximum daily dose: 40mL per kg of the patient's body weight (equivalent to amino acids 1.54g, glucose 4.8g, and fat 1.6g per kg of body weight)
Precautions
This medication should be used strictly according to a doctor's instructions, and administration must be immediately discontinued if any allergic reactions such as fever, tremors, rash, or difficulty breathing occur. When used with intravenous calcium preparations, avoid mixing or administering simultaneously. If the same infusion line is to be used, thorough washing is required. Particularly in premature or low birth weight infants, lipid metabolism can be challenging and pose risks, so caution is necessary. Do not administer to specific patient populations such as premature infants, neonates, those with allergies to eggs or soybean oil, and patients with severe renal or liver disease. In patients with renal failure, liver dysfunction, heart failure, diabetes, and other specific conditions, administration should be cautious, and blood lipid and electrolyte levels should be monitored frequently. Overdosage or rapid infusion can cause side effects; if symptoms such as fever, shaking, vomiting, or difficulty breathing appear, discontinue administration immediately. Long-term use may result in liver dysfunction or blood abnormalities, so regular testing is required. Before administration, fluid, electrolyte, and acid-base balance should be improved, and blood glucose and lipid levels should be monitored periodically. This medication may interact with other drugs; thus, consult with a specialist if other medications are being taken. During pregnancy or breastfeeding, the safety of this medication has not been established, so it should be administered with caution. When conducting blood tests, the lipid components in this medication may affect the test results, so it is advisable to have blood drawn 5 to 6 hours after administration. Severe symptoms such as acidosis, fluid overload, hyperglycemia, and dehydration may occur with overdose, so adhere strictly to dosage and administration rate. Do not use if the packaging is damaged or if the solution has deteriorated. Administer immediately after opening, and do not reuse any remaining solution. Ensure to maintain aseptic conditions during preparation for administration, and store in a sealed container protected from light at a cool temperature of 15 to 25°C; avoid freezing.
Side effects
- Increased body temperature
- sweating
- tremors
- headache
- vomiting
- respiratory distress
- elevated liver function test results
- hepatomegaly
- jaundice
- thrombophlebitis
Show 27 moreCollapse
- hyperlipidemia
- fever
- fatty infiltration
- splenomegaly
- anemia
- leukopenia
- thrombocytopenia
- coagulation abnormalities
- coma
- flushing
- chills
- loss of appetite
- nausea
- respiratory impairment
- pain in the thoracic and lumbar region
- hypertension
- hypotension
- hypersensitivity reactions
- skin erythema
- cyanosis
- tissue fat accumulation
- pathological liver dysfunction
- abnormal blood symptoms
- abdominal pain
- fatigue
- phlebitis
- thrombophlebitis
Not everyone experiences these, and they can vary from person to person.
Storage
This medication should be stored in a sealed container to avoid exposure to air and light, preferably in a cool temperature range of 15 to 25 degrees Celsius.
Appearance and packaging
Appearance
An emulsion for infusion, colorless and transparent, contained in a bag made of polyamide and polypropylene divided into three compartments: two on the top and one on the bottom.
Package unit
bag - 1875 milliliters/bag
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.